All

FDA Approves Durvalumab-Chemo Combo for Resectable NSCLC

The approval was based on trial results which showed the regimen reduced the risk of recurrence, progression, or death by 32% versus neoadjuvant chemotherapy alone.

All

New Cell Identified as Allergy Memory Keeper

Researchers have discovered a new type of memory B cell that plays a crucial role in remembering and reacting to allergens, a discovery they say could open new avenues for allergy treatment.

All

Immune-Affecting Drugs Amplify COVID-19 Severity

People taking some immune-affecting medications, including prednisone and mycophenolate mofetil, face significantly higher risks of severe COVID-19 outcomes, reveals a new study.

UIC Scientists Receive $13 Million to Study Lung Inflammation Mechanisms

by RT Staff | Mar 8, 2023 | ARDS, COPD, Pulmonary Fibrosis | 0

The researchers hope the projects will lead to new avenues for treatments to help patients with conditions like COPD, pulmonary fibrosis, and acute respiratory distress syndrome.

Researchers Discover Potential Way to Block Peanut Allergy Anaphylaxis

by RT Staff | Feb 21, 2023 | Allergies | 0

Researchers from Indiana University School of Medicine say the discovery could lead to life-saving therapeutics for people with severe peanut allergies.

Investigational Immune Activating Platform Boosts Influenza Vaccine Response

by RT Staff | Feb 17, 2023 | Influenza | 0

The preclinical research demonstrated the ability of Infectimune to significantly boost CD4 T cell activity, suggesting that Infectimune-based vaccines could provide durable protection against seasonal flu and potentially emerging pandemic flu.

FDA Approves Sublingual Drug for Dust Mite Allergy for Adolescents

by RT Staff | Jan 30, 2023 | Allergies, FDA Approvals | 0

The FDA expanded its approval of Odactra, a sublingual allergen extract to treat house dust mite-induced allergic rhinitis, to ages 12 through 17.

Fungal Lung Infections Could be Treated with CAR T-cells

by Lisa Spear | Sep 29, 2022 | Disorders & Diseases | 0

Fungal lung infections could be treated with modified immune cells known as CAR T-cells, a study in mice suggests.

Good Sleep, Good Immunity

by RT Staff | Sep 21, 2022 | Breathing Disorders, Insomnias | 0

Getting a consistent good night’s sleep supports normal production and programming of hematopoietic stem cells, a building block of the body’s innate immune system.

How Climate Change May Affect Sleep, Immunity

by RT Staff | Aug 18, 2022 | Environmental News, Infectious Diseases, Sleep Medicine | 0

A warming planet means less quality sleep, and sleep disturbance could make it harder for the body to fend off infection.

Gene Variant Indicates Effectiveness of Immunotherapy for Allergies

by RT Staff | Mar 7, 2022 | Allergies | 0

Results suggest that allergy patients carrying a genetic variant have an increased risk of being non-responders to sublingual immunotherapy in their second season of the immunotherapy.

COVID Antibodies Detected in 98% of Infants Born to Vaccinated Mothers

by RT Staff | Feb 19, 2022 | Coronavirus, Neonatal, Prenatal | 0

COVID-19 antibody levels were higher in vaccinated mothers and their umbilical cord blood at delivery than in those study participants infected with COVID.

Oral Immunotherapy Induces Remission of Peanut Allergy in Some Young Children

by RT Staff | Jan 21, 2022 | Allergies, Neonatal, Pediatric Care | 0

Giving peanut oral immunotherapy to highly peanut-allergic children ages 1 to 3 years safely desensitized most of them to peanut and induced remission of peanut allergy in one-fifth.